<DOC>
	<DOCNO>NCT01332084</DOCNO>
	<brief_summary>The investigator plan launch Specific Oral Tolerance Induction ( SOTI ) pilot study order ass efficacy safety hypoallergenic ( H.A . ) wheat cereal , child allergy wheat . The study potential offer desensitization treatment option child allergic wheat . The investigator hypothesize H.A . wheat cereal similar efficacy less side effect native wheat cereal .</brief_summary>
	<brief_title>Use Hypoallergenic ( H.A . ) Cereals Children With Diagnosed Allergy Wheat</brief_title>
	<detailed_description>In pilot study , investigator aim assess feasibility SOTI ( Specific Oral Tolerance Induction ) hypoallergenic ( H.A . ) cereal child diagnose IgE-Mediated allergy wheat . This multi centre , open , pilot study test 1 product.10 child ethnicity age 1 12 year old diagnose allergy wheat eligible participate study . The duration treatment 6 month minimum 1 month daily consumption hydrolyze wheat cereal . Each subject feed quantity assign study product accord SOTI . The SOTI perform hospital control qualify doctor nurse . The study product administer start low dosage , increase stepwise every 30 minute amount equivalent usual daily oral intake . Thereafter , study product correspond maximum dose tolerate give maintenance dose one serve every day final visit challenge test wheat perform assess tolerance whole wheat .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Food Hypersensitivity</mesh_term>
	<mesh_term>Wheat Hypersensitivity</mesh_term>
	<criteria>Infant ethnicity age 1 12 year old time enrollment Positive Skin Prick Test ( SPT ) wheat and/or Positive specific IgE wheat Immediate positive reaction ( IgEtype reaction ) wheat show provocation test do maximum 1 year enrollment study unambiguous history wheat allergy evaluate investigator Having obtain his/her signed legal representative 's informed consent Child systemic drug ( potentially affect allergic reaction e.g . antihistamine ) accord halflife time enrollment Congenital illness malformation may affect normal growth ( especially immunodeficiency ) Child uncontrolled asthma Child whose parents/caregivers expect comply treatment Child currently participate another interventional clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>SOTI</keyword>
	<keyword>tolerance</keyword>
	<keyword>desensitization</keyword>
	<keyword>challenge test</keyword>
	<keyword>HA wheat cereal</keyword>
</DOC>